Literature DB >> 19950795

Increases in soluble tumor necrosis factor receptors coincide with increases in interleukin-6 and proteinases after major surgery.

Koji Sasajima1, Ryouhei Futami, Takeshi Matsutani, Tsutomu Nomura, Hiroshi Makino, Hiroshi Maruyama, Masao Miyashita.   

Abstract

BACKGROUND/AIMS: To determine whether increases in soluble tumor necrosis factor receptors (sTNFRs) are associated with the levels of cytokines and proteinases in patients undergoing major surgery.
METHODOLOGY: Eleven patients who underwent esophagectomy for squamous cell carcinoma of the thoracic esophagus were studied. The circulating blood concentrations of interleukin-6 (IL-6), IL-8, sTNF-R55, sTNF-R75, elastase/al-proteinase inhibitor complex (elastase) and matrix metalloproteinase-9 (MMP-9) were measured by ELISA or EIA before surgery, just after surgery, and on postoperative days (POD) 1 and 3.
RESULTS: The levels of serum IL-6, plasma IL-8, plasma elastase and plasma MMP-9 increased significantly after surgery, peaking just after surgery or on POD 1 and then declining. In contrast, the serum levels of sTNFRs increased approximately 2-fold just after surgery compared with the preoperative values and then remained elevated. The IL-6 level correlated with the levels of sTNF-R55 and sTNF-R75 after surgery.
CONCLUSIONS: These results suggest that increases of IL-6, serine proteinases and MMPs may be involved in the upregulation of sTNFRs in patients undergoing major surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19950795

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Measurement of tumour necrosis factor receptors for immune response in colon cancer patients.

Authors:  K Venetsanou; V Kaldis; N Kouzanidis; Ch Papazacharias; J Paraskevopoulos; G Baltopoulos
Journal:  Clin Exp Med       Date:  2011-11-01       Impact factor: 3.984

2.  The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer.

Authors:  Junichi Nishiyama; Mitsumasa Matsuda; Satoko Ando; Miyoko Hirasawa; Toshiyasu Suzuki; Hiroyasu Makuuchi
Journal:  Surg Today       Date:  2011-12-27       Impact factor: 2.549

3.  Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma.

Authors:  Xiao He; Xiaoling Xu; Guanxia Zhu; Hong Ye
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.